1tvb: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1tvb.png|left|200px]] | [[Image:1tvb.png|left|200px]] | ||
{{STRUCTURE_1tvb| PDB=1tvb | SCENE= }} | {{STRUCTURE_1tvb| PDB=1tvb | SCENE= }} | ||
===Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2=== | ===Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2=== | ||
{{ABSTRACT_PUBMED_15814707}} | {{ABSTRACT_PUBMED_15814707}} | ||
== | ==About this Structure== | ||
[[1tvb]] is a 6 chain structure of [[Beta-2 microglobulin]] and [[Major histocompatibility complex]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TVB OCA]. | |||
== | ==See Also== | ||
*[[Beta-2 microglobulin|Beta-2 microglobulin]] | |||
*[[Major histocompatibility complex|Major histocompatibility complex]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015814707</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Baker, B M.]] | [[Category: Baker, B M.]] | ||
| Line 32: | Line 21: | ||
[[Category: Gp100]] | [[Category: Gp100]] | ||
[[Category: Hla-a2]] | [[Category: Hla-a2]] | ||
[[Category: Immune system]] | |||
[[Category: Melanoma]] | [[Category: Melanoma]] | ||
[[Category: Mhc]] | [[Category: Mhc]] | ||
[[Category: Peptide]] | [[Category: Peptide]] | ||
[[Category: X-ray]] | [[Category: X-ray]] | ||
Revision as of 20:32, 25 July 2012
Crystal structure of Melanoma Antigen gp100(209-217) Bound to Human Class I MHC HLA-A2
Template:ABSTRACT PUBMED 15814707
About this Structure
1tvb is a 6 chain structure of Beta-2 microglobulin and Major histocompatibility complex with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol. 2005 Apr 15;174(8):4812-20. PMID:15814707